Search research articles
Contact Us
Filters
Showing results (41-50 of 73) with videos related to
Page
of 8
Sort By:
JCO Oncology Practice
|
January 11, 2022
Impact of COVID-19 on Hematology-Oncology Fellowship Programs: A Quantitative and Qualitative Survey Assessment of Fellowship Program Directors
Ana I Velazquez, Urshila Durani, Lachelle D Weeks, et al.
The Oncologist
|
May 21, 2026
Patient-reported time toxicity with bispecific antibody therapies in relapsed/refractory follicular lymphoma and diffuse large B-cell lymphoma
Ajay Major, Esprit Ma, Anthony Masaquel, et al.
The Lancet. Haematology
|
May 30, 2025
Beyond maximum grade: introduction to The Lancet Haematology Adverse Events Reporting Series
Gita Thanarajasingam, Ajay Major, Vishal Bhatnagar, et al.
Haematologica
|
July 29, 2021
Phase I/II clinical trial of temsirolimus and lenalidomide in patients with relapsed and refractory lymphomas
Ajay Major, Justin Kline, Theodore G Karrison, et al.
JAMA Oncology
|
July 21, 2022
Elotuzumab and Weekly Carfilzomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Without Transplant Intent: A Phase 2 Measurable Residual Disease-Adapted Study
Benjamin A Derman, Ankit Kansagra, Jeffrey Zonder, et al.
Haematologica
|
December 18, 2023
Multi-gene measurable residual disease assessed by digital polymerase chain reaction has clinical and biological utility in acute myeloid leukemia patients receiving venetoclax/azacitidine
Amanda C Winters, Mohd Minhajuddin, Brett M Stevens, et al.
Leukemia & Lymphoma
|
March 31, 2022
Practice patterns for the management of nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL): an international survey by the Global NLPHL One Working Group (GLOW)
Andrea C Lo, Ajay Major, Leanne Super, et al.
Annals of Internal Medicine
|
November 3, 2025
The Michigan Appropriateness Guide for Intravenous Catheters in Adult Patients With Cancer (MAGIC-ONC): Results From a Multispecialty Panel Using the RAND/UCLA Appropriateness Method
Ajay Major, David G Paje, Knut Taxbro, et al.
Hemasphere
|
August 21, 2025
Early peripheral blood and bone marrow MRD as prognostic markers in quadruplet-treated multiple myeloma without transplant
Benjamin A Derman, Jennifer Cooperrider, Anna Pula, et al.
Journal of the National Cancer Institute
|
August 21, 2025
Mortality after colorectal cancer among survivors of childhood cancer
Ajay Major, Joanne Chou, Helen Lam, et al.
Page
of 8
Search research articles
Search
Showing results (41-50 of 73) with videos related to
Sort By:
Page
of 8
JCO Oncology Practice
|
January 11, 2022
Impact of COVID-19 on Hematology-Oncology Fellowship Programs: A Quantitative and Qualitative Survey Assessment of Fellowship Program Directors
Ana I Velazquez, Urshila Durani, Lachelle D Weeks, et al.
The Oncologist
|
May 21, 2026
Patient-reported time toxicity with bispecific antibody therapies in relapsed/refractory follicular lymphoma and diffuse large B-cell lymphoma
Ajay Major, Esprit Ma, Anthony Masaquel, et al.
The Lancet. Haematology
|
May 30, 2025
Beyond maximum grade: introduction to The Lancet Haematology Adverse Events Reporting Series
Gita Thanarajasingam, Ajay Major, Vishal Bhatnagar, et al.
Haematologica
|
July 29, 2021
Phase I/II clinical trial of temsirolimus and lenalidomide in patients with relapsed and refractory lymphomas
Ajay Major, Justin Kline, Theodore G Karrison, et al.
JAMA Oncology
|
July 21, 2022
Elotuzumab and Weekly Carfilzomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Without Transplant Intent: A Phase 2 Measurable Residual Disease-Adapted Study
Benjamin A Derman, Ankit Kansagra, Jeffrey Zonder, et al.
Haematologica
|
December 18, 2023
Multi-gene measurable residual disease assessed by digital polymerase chain reaction has clinical and biological utility in acute myeloid leukemia patients receiving venetoclax/azacitidine
Amanda C Winters, Mohd Minhajuddin, Brett M Stevens, et al.
Leukemia & Lymphoma
|
March 31, 2022
Practice patterns for the management of nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL): an international survey by the Global NLPHL One Working Group (GLOW)
Andrea C Lo, Ajay Major, Leanne Super, et al.
Annals of Internal Medicine
|
November 3, 2025
The Michigan Appropriateness Guide for Intravenous Catheters in Adult Patients With Cancer (MAGIC-ONC): Results From a Multispecialty Panel Using the RAND/UCLA Appropriateness Method
Ajay Major, David G Paje, Knut Taxbro, et al.
Hemasphere
|
August 21, 2025
Early peripheral blood and bone marrow MRD as prognostic markers in quadruplet-treated multiple myeloma without transplant
Benjamin A Derman, Jennifer Cooperrider, Anna Pula, et al.
Journal of the National Cancer Institute
|
August 21, 2025
Mortality after colorectal cancer among survivors of childhood cancer
Ajay Major, Joanne Chou, Helen Lam, et al.
Page
of 8